Evaluation of the Effectiveness of a Spa Treatment for People With Post-Covid 19 Conditions.
- Conditions
- Post COVID-19 Condition
- Registration Number
- NCT06570239
- Lead Sponsor
- Central Hospital, Nancy, France
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria:<br><br> - Person who has received full information about the organisation of the research, who<br> has not<br><br> - to their participation and the use of their data, and who have given their free and<br> free and informed consent in writing,<br><br> - Patients aged 18 and over,<br><br> - Patients with a history of symptomatic Covid-19 infection documented by RTPCR,<br> antigenic test, positive serology in a patient not previously vaccinated or other<br> virological diagnostic test validated at the patient's inclusion date,<br><br> - A person who has not required hospitalisation for treatment in the initial phase of<br> Covid-19,<br><br> - Person presenting at least two common symptoms of the post-Covid condition from<br> among fatigue, breathlessness, cognitive dysfunction, appearing de novo and evolving<br> for more than for more than 12 weeks and present for more than 8 weeks,<br><br> - Initial and prolonged symptoms not explained by another diagnosis with no known link<br> to with Covid-19,<br><br> - Normal SpO2 at rest not decreasing beyond 4% on exercise,<br><br> - Membership of a social security scheme or beneficiary of such a scheme.<br><br>Exclusion Criteria:<br><br> - Acute cardiovascular disease (acute coronary syndrome, arrhythmia, heart failure,<br> venous thromboembolism venous thromboembolic disease, myocarditis, stroke, acute<br> ischaemia, etc.) less than stroke, acute ischaemia, etc.) less than 3 months old and<br> at risk of recurrence or decompensation,<br><br> - Respiratory disease: COPD, interstitial fibrosis, exercise-induced desaturation,<br> sleep apnoea<br><br> - Stroke less than 6 months old,<br><br> - Pregnant women,<br><br> - Adults subject to a legal protection measure (guardianship, curatorship, safeguard<br> of justice),<br><br> - Serious and unstable psychiatric pathology, severe depressive syndrome, delirious<br> decompensation, panic attacks, anxiety-depression syndrome,<br><br> - Acute and progressive conditions (infectious, cancerous and inflammatory),<br><br> - Person with a contraindication to hydrokinesitherapy and crenotherapy crenotherapy<br> (infected dermatoses, severe immune deficiencies, inflammatory diseases, faecal or<br> urinary incontinence, presence of a suprapubic or intravenous catheter, colostomy,<br> hydrophobia)<br><br> - Refusal to sign the free and informed consent form
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Outcome
- Secondary Outcome Measures
Name Time Method Utility score (EQ-5D-5L);Number of symptoms and symptoms clusters;Return to work;Medical consultations